Slovenia
Industry
Half-yearly results from Slovenian pharmaceutical firm Krka have highlighted strong performance in the company's Western Europe and Overseas (which includes any markets outside of...
2008-08-26Industry
The first half of 2008 has brought mixed results for pharmaceutical companies operating in Romania. Often considered as a high potential market for investment, it appears that the...
2008-07-31Industry
Slovenia is the healthiest EU newcomer, according to a study on eliminating inequalities in health in the EU, presented in Ljubljana on 16 June 2008. The study, which assessed the...
2008-06-18Companies
US drugmaker Mylan has exercised its option to acquire Merck KGaA's Central and Eastern Europe (CEE) generics business, expanding its European footprint and gaining access to high...
2008-06-03Industry
Slovenian drugmaker Krka is to make its first venture into Western Europe with the planned acquisition for German generics firm TAD Pharma in a deal reported to be worth EUR97mn...
2007-11-14Companies
Leading Slovenian drugmaker Krka has officially opened its Sinteza 4 active pharmaceutical ingredient (API) production facility. The EUR80mn (US$107mn) plant will allow the firm to...
2007-06-21Companies
On the back of impressive 2006 financial results, Slovenian drugmaker Krka is looking to further penetrate emerging markets, continue to upscale its R&D capabilities, get more...
2007-02-13Companies
Slovenia's Krka has reached an out-of-court settlement with French firm Servier over a generic version of the latter's perindopril - an ACE inhibitor for the treatment of hypertension....
2006-11-17
